forward vs. inverse planning inverse planning techniques ... · 1 inverse planning techniques for...
TRANSCRIPT
1
Inverse Planning Techniques for IMRT
Ping Xia, Ph.D.
University of California-San Francisco
AAPM 2004, course TH-A-BRA CE
Forward vs. Inverse Planning
• Conventional forward planning mostly depends on geometric relationship between the tumor and nearby sensitive structures.
• Inverse planning is less dependent on the geometric parameters but more on specification of volumes of tumor targets & sensitive structures, as well as their dose constraints.
Inverse Planning Is Less Forgiving
• Only treat contoured tumor targets.
• Only spare contoured sensitive structures.
70 Gy, 59.4 Gy, 54.0 Gy, 45 Gy
Adding Artificial Structure
2
Volume Delineation
Volume Delineations
• How to define target volumes?• How to contour sensitive structures?• How many sensitive structures should
be contoured?
Sensitive Structure Delineation
• About 24 sensitive structures need to be contoured
• Lt & Rt parotid, optic nerves, eyes, lens, inner ears, TMJ ( 12).
• Spinal cord, brain stem, chiasm, brain, temporal lobes, larynx, mandible, tongue, airway, apex lung, neck skin, thyroid (12) …
What are Serial and Parallel Organs ?
• A Serial organ is damaged if one of its sub-volumes is damaged.
• A parallel organ loses its functionality only if all sub-volumes of the organ are damaged.
3
R T L T
2 9
3 0
3 1
3 2
3 3
3 4
3 5
3 6
3 7
3 8
Dose
(Gy)
ABCDE
Differences in Mean Dose to Parotid Glands
Tumor Margin vs Beam Margin
• Tumor margin: position uncertaintieslocalization uncertainties
• Beam margin: Beam penumbra
1.5 cm block margin = 0.8 cm tumor margin + 0.7 cm beam margin
3 mm superior
3D Tumor Margin or 2D Tumor Margin
4
Dose Constraints
Dose Constraints• Inverse planning requires us to specify dose constraints
to all structures.
• Inverse IMRT planning becomes a trial-error process in searching for a proper dose constraint specification.
• Improperly specified dose constraints will result in inferior plans
Tell Me Your Dream
• Full dose to the tumor target• Zero dose to sensitive structures
Impossible !!!!
Treatment GoalsRx doses:
95 % GTV > 70 Gy at 2.12 Gy95 % PTV > 59.4 Gy at 1.8 Gy
Tolerance doses:Spinal Cord: Max < 45 Gy,Brain Stem: Max < 55 Gy,Parotid glands: mean dose < 26 Gy,Optic structures: Max < 54 Gy,
5
Realty and Physics Limitations
• Single beam penumbra ~ 7-8 mm, from 90% - 20% iso-dose lines – 10%/mm
• IMRT iso-dose lines are also limited by this radiation physics.
• Scatter dose from multiple beams makes the beam penumbra shallower.
15 Gantry angles
60, 50, 42, 34 Gy
70%
40%
Systematic Trial-and-Error
Everything Equally Important
6
See What We Get
• Rx 70% to 66 Gy7% of GTV underdose, 10% of CTV underdose,
• Max-dose RT-eye = 64 Gy, LT-eye =61RT-OPN = 56 Gy, LT-OPN = 57 GyBrain Stem = 46 GyChiasm = 54 Gy
Everything Equally Important
Tumor Important
• Rx 84% to 66 Gy4 % of GTV underdose, 5% CTV underdose,
• Max-dose to critical structures RT-eye = 71 Gy, LT-eye =64 GyRT-OPN = 66 Gy, LT-OPN = 69 GyBrain Stem = 48 GyChiasm = 59 Gy
Tumor Important
7
What We Can Get Critical Structures Important
See What We GetCritical Structures Important
• Rx 75% to 66 Gy6 % of GTV underdose, 7% CTV underdose,
• Max-dose to critical structures RT-eye = 63 Gy, LT-eye =64 GyRT-OPN = 51 Gy, LT-OPN = 51 GyBrain Stem = 42 GyChiasm = 51 Gy
8
Compromise Solution Final Solution
Final Solution
• Rx 80% to 66 Gy6% of GTV underdose, 8% CTV underdose,
• Max-dose to critical structures RT-eye = 60 Gy, LT-eye =62 GyRT-OPN = 55 Gy, LT-OPN = 56 GyBrain Stem = 46 GyChiasm = 54 Gy
70 Gy, 60 Gy, 54 Gy, 45 Gy
Equal important
Critical structure
Tumor important
Compromised
9
Beam Angle Selection
Beam Selections
• Are more beams better than fewer beams?
• Equal spaced beam angles? • Non-coplanar beam angles?
Not necessarily
Non-coplanar Beam Angles
• Rx 80% to 66 Gy5% of GTV underdose, 8% CTV underdose,
• Max-dose to critical structures RT-eye = 62 Gy, LT-eye =63 GyRT-OPN = 49 Gy, LT-OPN = 51 GyBrain Stem = 39 GyChiasm = 53 Gy
15 Beam Angles
• Rx 82% to 66 Gy4 % of GTV underdose, 4% CTV underdose,
• Max-dose to critical structures RT-eye = 63 Gy, LT-eye =62 GyRT-OPN = 53 Gy, LT-OPN = 56 GyBrain Stem = 33 GyChiasm = 56 Gy
10
15 beam angles 9 beam angles
Non-coplanar beam angles
70 Gy, 60 Gy, 54 Gy, 45 Gy
Plan Refinement
Plan 1
Plan 2
Plan 1
11
Plan 2
Plan 1 Plan 2
70 Gy, 59.4 Gy, 52 Gy
Plan Evaluation
Evaluation of IMRT Plans
• Define endpoints• Dose volume histogram (DVH)• Dose distributions on every CT slice
(Rx, hot spot, cold spot)
12
Plan Acceptance Criteria
Head and Neck Tumor:
> 80% isodose line to the GTV
70 Gy > 95% of GTV (2.12 Gy/day)59.4 Gy > 95% of CTV (1.8 Gy/day)54 GY > 95% of CTV2 (1.64 Gy/day)
• Sensitive Structures:Serial Structures: Maximum dose
Cord < 45 Gy, 1cc < 40 GyStem < 54 Gy, 1 cc < 54 GyOptic structures < 54 GyMandible < 70 GyTemporal lobe < 70 Gy
Plan Acceptance Criteria
• Parallel Structures: Mean doseParotid < 26 Gy~ 30 Gy
Inner ear < 50 Gy
Other Structures: as low as possibleOral cavitysub-mandibular glandLarynx
Plan Acceptance Criteria
Isodose Distributions
13
Cold spot
70 Gy,59.4 Gy,45 Gy
Hot-spot
70.0 Gy,59.4 Gy,54 Gy
6 mm superior
Three Dimensional Examination
70 Gy60 Gy
70 Gy60 Gy
Class Solutions
14
Review Old Plans• Review previous clinically accepted plans
9 plans for T1-2 Nasopharyngeal patients.16 plans for T3-4 Nasopharyngeal patients.
24 plans for oropharyngeal patients.
(Xia, P et. al, IJROBP, in press)
31.338.3 41.4 Mid./Inner Ear
26.7 30.5 33.8 T-M joint17.9 25.1 26.8
Parotid Gland
Dose to 80% Vol. (Gy)
Dose to 50% Vol. (Gy)
Mean Dose (Gy)
9.8 13.5 25Eye18.8 22.2 23.7 Optic Nerve37.6 40.4 50.9 Brain Stem25.8 30.6 38.3 Spinal Cord 19.7 21.5 27.5 Chiasm
Dose to 10% Vol. (Gy)
Dose to 5% Vol. (Gy)
Max. Dose (Gy)Structures
T1-2 Nasopharyngeal Cancer
42.249.8 49.6Middle/Inner Ear
31.5 36.7 38T-M joint18.7 24.6 27.8Parotid Gland
Dose to 80% Vol. (Gy)
Dose to 50% Vol. (Gy)Mean Dose (Gy)
19.6 21.9 32.8 Eye31.634.4 41.6 Optic Nerve40.0 43.1 55.3 Brain Stem26.7 33.0 42.2Spinal Cord 34.236.442.7Chiasm
Dose to 10% Vol. (Gy)
Dose to 5% Vol. (Gy)Max Dose (Gy)Structures
T3-4 Nasopharyngeal Cancer PTV70
PTV70
PTV70
PTV60
PTV60
PTV60
Cord
Lt Parotid
Rt Parotid
Brainstem
AntiPTV
Parotids
Q block
15
79.2, 70.0, 59.4, 54.0, 45.0 GyArtificial structure
airway
Neck skin
79.2, 70.0, 59.4, 54.0, 45.0 Gy
cord
stem
Parotids
GTV
PTV
PTV2
Nasopharynx Tumor Target –Oropharyngeal Cancer
9.0 ± 4.8
80.8 ± 2.0
60.6± 2.7
54.3 ±4.7
690.4 ± 274.1
PTV-60
0.1 ± 0.1
80.2 ± 2.6
71.2± 1.5
69.3 ± 1.4
76.7 ± 47.3
PTV-70
V93% (cc)
D1cc (Gy)
D95% (Gy)
D99% (Gy)
Vol. (cc)
Rx IDL 85.8% ±±±± 2.0%
16
Sensitive Structures – Oropharyngeal Cancer
26.2± 7.5
26.9 ± 7.6
TMJ67.7± 3.0
71.6± 2.9
Mandible
23.3 ± 8.9
24.2 ± 8.6
Ear40.1± 10.1
43.5± 9.8
Brain Stem
23.5 ± 3.5
26.1 ± 3.2
Parotid40.2 ± 3.8
42.6 ± 3.5
Spinal Cord
Median (Gy)
Mean (Gy)
D1% (Gy)
D1cc (Gy)
78.2 Gy70.0 Gy59.4 Gy54.0 Gy45.0 Gy
Oropharynx
Oropharynx
78.2 Gy, 70.0 Gy, 59.4 Gy, 54.0 Gy, 45 Gy
GTV
PTV
Brain stem
cord
Parotids
Oropharynx
17
Class Solutions• Class solutions can be applied to patients with
same or similar types of cancer• Streamline treatment planning can significantly
improve planning efficiency. • Planning turn around time has been reduced from
one week to two days. • Actual planning time for a typical head and neck
case is about 4-8 hours, including contouring , printing, waiting, coffee break…
Simplify IMRT Plans
Seeking Simple IMRT Plans
• Five oropharyngeal cases were planned using five different beam angle arrangements.
• The criteria for plan acceptance are based on RTOG protocols (RTOG-0022)
• Five patients were not limited to early stage as in RTOG protocol.
Submitted to Int. J. Radiat. Oncol. Biol. Phys
Tumor Target –Oropharyngeal Cancer
9.0 ± 4.8
80.8 ± 2.0
60.6± 2.7
54.3 ±4.7
690.4 ± 274.1
PTV-60
0.1 ± 0.1
80.2 ± 2.6
71.2± 1.5
69.3 ± 1.4
76.7 ± 47.3
PTV-70
V93% (cc)
D1cc (Gy)
D95% (Gy)
D99% (Gy)
Vol. (cc)
Rx IDL 85.8% ±±±± 2.0%
18
Sensitive Structures – Oropharyngeal Cancer
26.2± 7.5
26.9 ± 7.6
TMJ67.7± 3.0
71.6± 2.9
Mandible
23.3 ± 8.9
24.2 ± 8.6
Ear40.1± 10.1
43.5± 9.8
Brain Stem
23.5 ± 3.5
26.1 ± 3.2
Parotid40.2 ± 3.8
42.6 ± 3.5
Spinal Cord
Median (Gy)
Mean (Gy)
D1% (Gy)
D1cc (Gy)
9 Equally Spaced 8 selected angles
0O
200O 160O
240O
320O
120O
40O
80O
0O
30O340O
290O
230O
90O
130O
280O
260O
7 selected anglesForward plan
7 angles fromMSKCC
210O
270O
150O
90O
180O
120O240O
0O
210O 150O
60O
90O270O
300O
Five beam angles
230O
65O
0O
130O
295O
19
PTV70
PTV70
PTV70
PTV60
PTV60
PTV60
Cord
Lt Parotid
Rt Parotid
Brainstem
AntiPTV
Parotids
Q block
Isodose line covering 95% of GTV
0.84
0.85
0.86
0.87
0.88
0.89
9 angles 8 angles 7 angles 7 angles(MSKCC)
5 angles FPMS
isod
ose
line
(%)
Target Volume Coverages (V70/V59.4)
90.00
92.00
94.00
96.00
98.00
100.00
9 angles 8 angles 7 angles 7 angles(MSKCC)
5 angles FPMS
Volu
me
(%)
GTV/CTV
Endpoint doses to sensitive structures
2000.00
2500.00
3000.00
3500.00
4000.00
4500.00
9 angles 8 angles 7 angles 7 angles(MSKCC)
5 angles FPMS
Dose
(cG
y)
Mean dose to parotid Max dose to 1 cc of cord
20
Treatment delivery time
0.00
5.00
10.00
15.00
20.00
25.00
9 angles 8 angles 7 angles 7 angles(MSKCC)
5 angles
Tim
e(m
in)
7000 cGy6000 cGy4500 cGy2500 cGy
7000 cGy6000 cGy4500 cGy2500 cGy
Seeking Simple IMRT Plans
• For simple H&N cases (oropharyngeal),5-6 beam angles with 60-80 segments~ 15-20 minutes.
• For complex H&N cases (naso, sinus), 7-8 beam angles with 100-130 segments ~ 20 – 30 minutes.
Submitted to Int. J. Radiat. Oncol. Biol. Phys
21
Special Clinical Problems-Skin Dose Problem
Patient with marked skin reaction
Patient Skin Dose Problem• Multiple tangential beams decrease skin sparing.
• Bolus effect, due to the use of the head-shoulder mask, increases skin dose about 15%.
• In order to cover superficial nodes, the inverse planning system increases beam intensity onthe neck skin.
• Neck skin may be contoured as a sensitive structure to avoid high dose on the neck skin.
Lee, N, et. al. IJROBP, 2002.
38.7047.5441.1050.3454.6460.1043.1250.63Ave. Total dose (Gy)
1.17 +0.10
1.44 +0.12
1.25 +0.17
1.53 +0.16
1.66 + 0.15
1.82 +0.13
1.31 + 0.31
1.53 + 0.39
Ave. Daily dose (Gy)
w/o mask
w/ mask
w/o mask
w/mask
w/o mask
w/mask
w/o mask
w/mask
IMRT w/skin excluded + skin
spare
IMRT w /skin excluded
IMRT w/ skin included
Opp. Lateral
Skin Dose Investigation
22
807060504030201000
20
40
60
80
100
Non-Skin Sparing PlanSkin Sparing Plan
Dose (Gy)
Volu
me
(%)
Patient neck skin sparing
Take Home Messages• Inverse planning is not intuitive but easy to establish
class solution for a specific cancer.• Know the realistic goals, find the upper limit and lower
limits for both dose conformity and uniformity.• Systematically research for compromise solution
– Find a proper dose constraints while
starting with 9 –11 beam angles– Find a optimal beam angles while
keeping the same dose constraints
Take Home Messages
• Once you know the upper and lower limits, simplify IMRT plan as much as possible to reduce treatment time, unnecessary radiation…
• Develop your own class solutions